FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

  • The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending the decades-long epidemic caused by the virus.